CasCure Therapeutics
Ulsan
About CasCure Therapeutics
CasCure Therapeutics develops personalized chemotherapy technology. The company uses artificial intelligence algorithms and deep learning technology for pipeline devices, such as Platform C for developing precision cancer medicines and Platform H for anti-cancer drugs, to provide medical professionals with a solution to cure cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: Seed
- Last round: Seed (Jan 2022)
- Website: cascure.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/cascure-therapeutics-2675806 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.